Skip to main content
. 2018 Dec 18;13(12):e0208454. doi: 10.1371/journal.pone.0208454

Table 1. Participant demographic and disease characteristics at baseline (mITT population).

Parameter Mg–vit B6 combination (N = 132) Mg (N = 132) Total (N = 264)
Age (years), mean (SD) 31.2 (8.4) 32.1 (8.6) 31.6 (8.5)
Sex female, n (%) 98 (74.2) 97 (73.5) 195 (73.9)
BMI, kg/m2, mean (SD) 23.0 (3.0) 22.9 (2.7) 23.0 (2.8)
BMI category, n (%)
     Normal (18.5–<25 kg/m2) 101 (76.5) 102 (77.3) 203 (76.9)
     Overweight (25–<30 kg/m2) 31 (23.5) 30 (22.7) 61 (23.1)
Systolic blood pressure (mmHg), mean (SD) 118.2 (13.4) 116.7 (11.1) 117.4 (12.3)
Diastolic blood pressure (mmHg), mean (SD) 73.9 (9.1) 72.8 (8.3) 73.4 (8.7)
Heart rate (bpm), mean (SD) 68.1 (12.8) 67.6 (11.6) 67.9 (12.2)
Serum Mga (mmol/L)
     Mean (SD) 0.80 (0.0) 0.80 (0.0) 0.80 (0.04)
     Median (Min, Max) 0.80 (0.7, 0.8) 0.80 (0.7, 0.8) 0.82 (0.66, 0.84)
Erythrocyte Mg (mmol/L), mean (SD) 1.80 (0.30) 1.80 (0.40) 1.83 (0.31)
Serum B6 (nmol/L), mean (SD) 50.6 (68.8) 46.5 (27.6) 48.6 (52.3)
DASS-42 stress subscale score, mean (SD) 27.7 (7.3) 27.6 (7.0) 27.7 (7.1)
DASS-42 total score, mean (SD) 58.3 (21.3) 58.4 (20.9) 58.4 (20.9)

aAt screening visit;

BMI, body mass index; bpm, beats per minute; DASS, Depression Anxiety Stress Scales; mITT, modified intention-to-treat; Mg, magnesium; SD, standard deviation; Vit B6, vitamin B6.